Expert Opinion About the Pharmacoeconomic Edge of Low-Cost Dapagliflozin in Type 2 Diabetes Mellitus in Indian Clinical Settings

Background This study aimed to understand the attitudes, beliefs, and concerns of physicians across India regarding the economic burden of diabetes and subsequently the cost-effectiveness of low-cost dapagliflozin for the management of patients with uncontrolled type 2 diabetes mellitus (T2DM) on ba...

Descripción completa

Detalles Bibliográficos
Autores principales: Sharma, Kamal, Chandorkar, A B, Kovil, Rajiv, Venkataraman, S, Subrahmanyam, KAV, Mandal, Parthasarathi, Wasir, Jasjeet, Abhyankar, Mahesh, Prasad, Ashish, Sarda, Prashant S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Endocrinology/Diabetes/Metabolism
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8642133/
https://www.ncbi.nlm.nih.gov/pubmed/34877189
http://dx.doi.org/10.7759/cureus.19194

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8642133/
https://www.ncbi.nlm.nih.gov/pubmed/34877189
http://dx.doi.org/10.7759/cureus.19194

Ejemplares similares